NEO

#1894
NeoGenomics, Inc. - Common Stock
10.5 2 USD
+3.14%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
10.52
10.52
Intervallo Annuale
4.72
13.74
Variazione giornaliera
+3.14%
Variazione Mensile
+16.11%
Variazione di 6 mesi
-12.33%
Variazione Annuale
+42.93%
Chiusura Precedente
10.2 0
Open
10.5 2
Minimo
10.5 2
High
10.5 2
Volume
154
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 1.37 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Diagnostica e Ricerca
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.95
Rapporto prezzo/fatturato
2.07

NeoGenomics, Inc. - Common Stock

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

Notizie